HEXO Stock Price to Fall If Management Misses Tight Deadline

Marijuana firm HEXO’s stock price fell 28% after earnings on Monday; expect more bad news if management fails to meet 2 April deadlines.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canadian cannabis producer HEXO’s (TSX:HEXO)(NYSE:HEXO) stock fell over 28% after earnings on Monday and the share price could fall further in April. The company’s latest quarterly financial results for fiscal Q2 2020 show management is racing against time to avoid a potential bankruptcy situation. The clock is ticking fast.

Perhaps we can have a quick look at quarterly performance before discussing management’s race to beat two critical deadlines in April.

Were HEXO’s Q2 2020 earnings really that bad?

Not really.

The company reported a 17% sequential growth in net revenue for the quarter to January 31. Adult-use cannabis segment volumes surged 57% sequentially as a recently launched value brand Original Stash steals the show in Canadian marijuana retail stores.

However, realized prices per gram continue to fall as Original Stash’s sales volumes increasingly contribute to the company’s sales revenue. The company is fighting the underground market with legit pot at matching prices, and its value brand is getting listed in a more provinces. Price competition has intensified, but at the expense of gross margins.

Excise taxes eating into margins

Unfortunately, as low-priced offerings grew in volumes, excise taxes as a percentage of revenue are rising too. Excise taxes are volume based, and the company is pushing higher volumes at reduced average prices. Excise taxes comprised 27% of gross revenue over the past six months, up from 18% historically.

But that’s not a very big issue, there were bigger matters that dragged the company’s stock price down on Monday.

Persistent cannibalization, and a lost segment

Medical cannabis sales volumes continue to decline for a fifth consecutive quarter. Patients seem to be switching to lower priced recreational offerings. The firm also registered zero wholesale revenue for the second quarter in a roll.

Anyway, this segment could be dying fast if we consider the current market oversupply after everyone ramped up production last year.

Persistent write-downs, massive impairment charges

Massive inventory write-downs continue, and significant write-offs were made as previously warned.

A $16 million inventory charge was levied during the reported quarter.  This time, the write-down is mainly due to a concentrated bulk purchase under a supply agreement acquired through Newstrike. Management believes contract prizes were negotiated in bad faith “…at prices well in excess of market.” The supply agreement is already under litigation.

The company recorded over $250 million in assets and goodwill impairment charges during the quarter, while operating expenses ballooned to $281.5 million against quarterly net revenue of $17 million.

Business is just bad right now, but this is not as concerning as the critical liquidity issues raised that threaten the company’s going concern status today. Management has to act fast to avoid a spiral of negative and self-reinforcing events.

Potential default in weeks — and a magnified bankruptcy threat

Management has issued a going concern note in the company’s financial statements that seeks to explain the fact that the company is significantly underfunded and may be unable to meet its financial obligations over the next 12 months without new financing. Yet the equity markets are drying up.

Further, the company needs new capital in a few weeks’ time or it will breach a critical financial covenant tied to a $65 million syndicated bank loan. In the recently revised loan terms, management has been given up to April 30, 2020 to raise new equity from the market or else the company will default on its loan terms.

According to the updated covenants, the company should raise at least $15 million in new equity by April 10. Further, management should secure at least $40 million from equity investors by April 30.

Given the current market crash and a COVID-19 stricken financial market, times couldn’t have been worse. The company is scurrying for new financing during a global crisis. Management might fail to meet the tight deadlines.

I hope things will work out fine. If they don’t, a default could take place in April, potentially triggering a downward spiral that could quickly result in a bankruptcy situation —  HEXO’s stock price could plunge in April.

Should you invest $1,000 in Superior Plus Corp. right now?

Before you buy stock in Superior Plus Corp., consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Superior Plus Corp. wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »